Newsroom

Sorted by: Latest

-

ペレグリンとシナールプリメーラ、インドネシアの一大コールドストレージ事業の構築に向け提携

シンガポール/インドネシア、ジャカルタ--(BUSINESS WIRE)--(ビジネスワイヤ) -- アジアで統合型コールドストレージおよび物流プラットフォームを展開するペレグリン・コールド・ロジスティクス(Peregrine Cold Logistics、以下「ペレグリン」)は、インドネシアを代表するニューエコノミー不動産デベロッパーの一社であるシナールプリメーラとの合弁事業を通じ、インドネシア市場に参入すると発表しました。両社は、インドネシア全土で最高水準のコールドストレージ施設を取得・開発します。本提携では、シナールプリメーラが所有するプルイットの既存施設を取得するとともに、ナロゴンで新規開発を行います。 シナールプリメーラとの提携は、ペレグリンの事業拡大における次のステップとなります。今回の提携により、フィリピンで展開する既存のコールドチェーン・プラットフォームに加え、ASEANおよび湾岸協力理事会(GCC)の高成長市場を結ぶペレグリンの統合ネットワークがさらに拡大します。東南アジア最大の経済国であるインドネシアへの参入は、同国で近代的な温度管理インフラへの需要が急速に高まっ...
-

Comentario de Best: No se espera que la actividad sísmica en el suroeste de Perú genere graves pérdidas aseguradas graves

CIUDAD DE MÉXICO--(BUSINESS WIRE)--AM Best espera que las pérdidas aseguradas derivadas del reciente terremoto en Perú sean limitadas debido a la baja penetración de seguros en la zona del epicentro. El comentario de Best, "No se espera que la actividad sísmica en el suroeste de Perú genere graves pérdidas aseguradas graves", AM Best afirma que la penetración de seguros en Perú es baja, aproximadamente el 2% del PIB en 2025, con la actividad aseguradora geográficamente concentrada. A junio de 2...
-

Kaname Capital Publishes Anonymous Letter on the Third-Party Committee Investigation at Fukuda Denshi and Calls on the Committee to Investigate Thoroughly

BOSTON--(BUSINESS WIRE)--Kaname Capital, L.P. (“Kaname Capital” or “we”) today published an anonymous letter that identifies problems with the Third-Party Committee investigation at Fukuda Denshi Co., Ltd. (TSE: 6960; “Fukuda Denshi”), and called on the Committee to conduct a thorough investigation. Please read the documents linked at the end of this release. The letter alleges that, although President Shirai and other members of the current executive team are suspected of using company expense...
-

Mobix Labs (Nasdaq: MOBX) Drone Acquisition Target Vision Aerial Opens Vulcan Orders, Projects 93% Revenue Growth in 2027

IRVINE, Calif.--(BUSINESS WIRE)--Mobix Labs, Inc. (Nasdaq: MOBX) (“Mobix Labs”) today highlighted commercial progress at Vision Aerial, Inc. (“Vision Aerial”), the American drone manufacturer Mobix Labs has signed a definitive agreement to acquire. Vision Aerial announced earlier today that it has opened orders for its new Vulcan aircraft family, with management projecting approximately 46% revenue growth in 2026 followed by approximately 93% growth in 2027. Vision Aerial's projected growth ali...
-

KBRA Releases 12 Things in Credit: July 2026

NEW YORK--(BUSINESS WIRE)--KBRA releases its latest 12 Things in Credit report, highlighting timely credit market themes drawn from our weekly podcast, 3 Things in Credit, hosted by KBRA’s Chief Strategist, Van Hesser. Among the wide-ranging topics Van discusses in this issue are the return of uncertainty, rising rates in the long-end of the Treasury market, and dimensioning the impact of data centers on the broader economy. Each Friday, the podcast covers three Things impacting credit that mar...
-

MEX Exchange, Part of MultiBank Group, Announces Senior Leadership Appointments

DUBAI, United Arab Emirates--(BUSINESS WIRE)--MEX Exchange, the institutional electronic trading platform of MultiBank Group, has announced two senior leadership appointments, with David Ogg promoted to Vice Chairman and Brian Andreyko promoted to Chief Executive Officer. The appointments strengthen the company’s leadership as it advances the development of its institutional electronic trading platform. David Ogg brings more than four decades of experience in foreign exchange trading and tradin...
-

A BeOne Medicines anuncia novos dados de sobrevida de fase 3 que reforçam o benefício de regimes contendo ZIIHERA no tratamento de primeira linha do câncer gastroesofágico HER2+

SAN CARLOS, Califórnia--(BUSINESS WIRE)--A BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), empresa global do setor de oncologia, anunciou hoje os resultados positivos da segunda análise intermediária (IA2) do estudo de Fase 3 HERIZON-GEA-01. O estudo avalia o uso do ZIIHERA®(zanidatamabe) em combinação com a quimioterapia, com ou sem o TEVIMBRA® (tislelizumabe), como tratamento de primeira linha para adenocarcinoma gastroesofágico (GEA) HER2-positivo localmente avançado ou metastá...
-

Emmaus Life Sciences Announces Agreement for Evaluation of L-glutamine for Pancreatic Cancer

TORRANCE, Calif.--(BUSINESS WIRE)--Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today announced that it has entered into an exclusive option agreement with Cedars-Sinai to continue investigating the clinical utility of L-glutamine oral powder in combination with chemotherapy, as a potential treatment for Pancreatic Ductal Adenocarcinoma (PDAC). The continuing research seeks to evaluate the efficacy and...
-

Submissions Now Open for the 2027 Phenom HR Awards

PHILADELPHIA--(BUSINESS WIRE)--Submissions Now Open for the 2027 Phenom HR Awards...
-

UBS Announces Leadership Appointments in the South Market

ATLANTA--(BUSINESS WIRE)--UBS today announced leadership appointments in its South wealth management market, which covers Georgia, Tennessee and Arkansas. John Houlihan has been named Market Executive for the South Market and is responsible for overseeing the market’s Private Wealth Management and Wealth Management businesses. John is based in Atlanta and previously served as Market Director for the firm’s Northeast region. Ian Roth has joined UBS as Senior Market Director, reporting to John. H...